CA Stock MarketDetailed Quotes
NIRV Nirvana Life Sciences Inc
- 0.075
- 0.0000.00%
15min DelayMarket Closed Aug 30 15:49 ET
3.62MMarket Cap-2500P/E (TTM)
0.000High0.000Low0Volume0.000Open0.075Pre Close0.00Turnover0.08052wk High0.00%Turnover Ratio48.23MShares0.01052wk Low-0.03EPS TTM2.61MFloat Cap0.950Historical HighLossP/E (Static)34.83MShs Float0.010Historical Low-0.04EPS LYR0.00%Amplitude--Dividend TTM-4.41P/B1Lot Size--Div YieldTTM
Nirvana Life Sciences Inc Key Stats
Quarterly+Annual
YOY
| (Q3)Jan 31, 2024 | (Q2)Oct 31, 2023 | (Q1)Jul 31, 2023 | (FY)Apr 30, 2023 | (Q4)Apr 30, 2023 | (Q3)Jan 31, 2023 | (Q2)Oct 31, 2022 | (Q1)Jul 31, 2022 | (FY)Apr 30, 2022 | (Q1)Jan 31, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow (Indirect Method) | ||||||||||
| Cash from operating activities | ||||||||||
| Net profit before non-cash adjustment | 102.13%5.02K | 38.63%-168.73K | -31.74%-361.5K | 73.63%-1.49M | ---706.19K | ---235.94K | -6,046.92%-274.93K | -401.52%-274.41K | -2,122.88%-5.66M | -84.24%-100.81K |
| -Depreciation and amortization | -46.71%12.21K | --0 | --0 | -0.00%91.64K | --22.91K | --22.91K | --22.91K | --22.91K | --91.65K | ---- |
| -Assets reserve and write-off | ---- | ---- | --0 | --0 | ---- | ---- | ---- | --3.84K | --319.48K | ---- |
| -Remuneration paid in stock | --28.14K | --46.26K | --76.53K | --204.59K | ---- | ---- | ---- | ---- | --0 | ---- |
| -Other non-cash items | -13,988.89%-175K | 3,579.56%175K | 117.33%665 | -94.34%253.37K | --251.19K | --1.26K | --4.76K | 50.48%-3.84K | 43,788.53%4.48M | ---- |
| Changes in working capital | -35.18%121.17K | -61.61%52.02K | -77.88%32.23K | 35.59%375.98K | ---92.19K | --186.91K | 287.30%135.5K | 199.91%145.76K | 154.97%277.29K | -121.55%-10.47K |
| -Change in receivables | 1,072.67%6.16K | -108.11%-1.75K | 69.35%-6.26K | -133.63%-2.68K | ---3.21K | ---633 | 1,578.42%21.59K | -1,593.20%-20.42K | 192.70%7.97K | -198.01%-3.59K |
| -Change in prepaid assets | -99.75%225 | -99.74%224 | -86.26%11.65K | 703.47%54.77K | ---205.25K | --90.12K | --85.13K | --84.77K | 81.09%-9.08K | ---- |
| -Change in payables | 17.82%114.78K | 86.02%53.55K | -67.03%26.84K | 16.35%323.89K | --116.28K | --97.42K | -21.02%28.79K | 63.45%81.41K | 68.36%278.39K | -113.81%-6.88K |
| Dividends paid (cash flow from operating activities) | ||||||||||
| Dividends received (cash flow from operating activities) | ||||||||||
| Interest paid (cash flow from operating activities) | ||||||||||
| Interest received (cash flow from operating activities) | ||||||||||
| Tax refund paid | ||||||||||
| Other operating cash inflow (outflow) | ||||||||||
| Operating cash flow | 65.95%-8.46K | 39.06%-70.45K | 15.32%-105.07K | 32.02%-333.21K | ---68.68K | ---24.85K | -391.84%-115.6K | -794.87%-124.08K | -214.28%-490.19K | -702.55%-111.28K |
| Investing cash flow | ||||||||||
| Net PPE purchase and sale | ---- | ---- | ---- | --0 | ---- | ---- | ---- | ---- | --0 | ---- |
| Net business purchase and sale | ---- | ---- | ---- | --0 | ---- | ---- | ---- | ---- | --106.16K | ---- |
| Net changes in other investments | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---207K | ---185K |
| Investing cash flow | ---- | ---- | ---- | --0 | --0 | --0 | --0 | --0 | ---100.84K | ---185K |
| Financing cash flow | ||||||||||
| Net issuance payments of debt | -91.61%1.96K | --21.66K | ---50K | 2,105.56%50K | ---33.06K | --23.37K | ---- | ---- | 108.76%2.27K | -94.98%1.24K |
| Net common stock issuance | --0 | --25K | 23.38%185.07K | --150K | --0 | --0 | --0 | --150K | --0 | ---- |
| Cash dividends paid | --0 | --0 | --0 | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
| Interest paid (cash flow from financing activities) | --0 | --0 | ---9.06K | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
| Net other fund-raising expenses | ---- | ---- | 454.34%8.03K | --109.93K | ---- | ---- | ---- | ---2.27K | ---- | ---- |
| Financing cash flow | -91.61%1.96K | -37.65%38.63K | -9.27%134.04K | 13,571.55%309.93K | --76.88K | --23.37K | 240.18%61.96K | 499.40%147.73K | -99.64%2.27K | -94.98%1.24K |
| Net cash flow | ||||||||||
| Beginning cash position | 66.78%9.64K | -30.23%41.46K | -65.08%12.49K | -94.27%35.77K | --4.3K | --5.78K | 355.88%59.42K | 1,487.62%35.77K | 27,619.88%624.53K | 21,017.89%475.79K |
| Current changes in cash | -337.91%-6.5K | 40.68%-31.82K | 22.47%28.97K | 96.05%-23.28K | --8.2K | ---1.49K | -1,068.61%-53.64K | 119.37%23.65K | -224.33%-588.76K | -2,836.70%-295.04K |
| End cash Position | -26.96%3.14K | 66.78%9.64K | -30.23%41.46K | -65.08%12.49K | --12.49K | --4.3K | -31.55%5.78K | 355.88%59.42K | -92.48%35.77K | 1,286.70%180.74K |
| Free cash flow | 65.95%-8.46K | 39.06%-70.45K | 15.32%-105.07K | 32.02%-333.21K | ---68.68K | ---24.85K | -391.84%-115.6K | -794.87%-124.08K | -214.28%-490.19K | -702.55%-111.28K |
| Accounting Standards | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP |
| Audit Opinions | -- | -- | -- | -- | -- | -- | -- | -- | Unqualified Opinion with Explanatory Notes | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.
Heat List
CA
Overall
Symbol
Latest Price
% Chg
No Data